Tandem Diabetes Care

• NCT04201496

  Collaborator, Phase 1, Completed, 34 people, 17 Dec 2019

• The Case for Evaluating Continuous Glucose Monitoring as a Diagnostic Tool for Diabetes

  Fees or honoraria, 8 Oct 2026

• Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study

  Fees or honoraria, 31 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Cardiovascular Outcomes Associated with GLP-1 Receptor Agonist Use among Adults with Type 1 Diabetes and Overweight or Obesity: A Target Trial Emulation Using Real-World EHR Data

  ADA Scientific Sessions 2026 abstract, 8 Jun 2026

• Semaglutide Use Along with Neural Network Fully Closed-Loop Systems Improves Time in Range (TIR) to 87% in Adults with Type 1 diabetes: In Silico Study

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• More Than Hot Flashes: Menopause Stages and Diabetes Management Burden

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Prevalence and Characterization of Underlying Preoperative Dysglycemia in Surgical Patients without Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Higher Risk of Noncardiovascular Death in a Population-Based Cohort of Type 1 Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025